The impact of low-dose versus high-dose antibiotic prophylaxis regimens on surgical site infection rates after cesarean delivery.


Journal

Archives of gynecology and obstetrics
ISSN: 1432-0711
Titre abrégé: Arch Gynecol Obstet
Pays: Germany
ID NLM: 8710213

Informations de publication

Date de publication:
01 2020
Historique:
received: 11 07 2019
accepted: 30 10 2019
pubmed: 8 12 2019
medline: 9 7 2020
entrez: 8 12 2019
Statut: ppublish

Résumé

The objective of this study was to determine if high-dose antibiotic prophylaxis with cefazolin decreases the risk of surgical site infection (SSI) after a cesarean delivery. We performed a retrospective cohort study of women who underwent a cesarean section. Two preoperative antibiotic regimens were compared: low dose versus high dose. The primary outcome was SSI. A sample size of 343 patients per group was calculated for a 50% reduction in risk for SSI. Seven hundred and thirty women were included with an incidence of SSI of 5%. Women who received the high-dose antibiotic regimen had lower rates of risk factors for SSI. The only exception was skin incision closure with staples. The rate of SSI did not differ between the low-dose and high-dose groups, even after adjusting for confounding variables [aOR 1.78, 95% CI (0.82-3.9)]. Higher doses of antibiotic prophylaxis did not decrease the rates of SSI after cesarean delivery.

Identifiants

pubmed: 31811413
doi: 10.1007/s00404-019-05370-y
pii: 10.1007/s00404-019-05370-y
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

69-73

Références

Betran AP, Ye J, Moller AB, Zhang J, Gulmezoglu AM, Torloni MR (2016) The increasing trend in caesarean section rates: global, regional and national estimates: 1990–2014. PLoS ONE 11:e0148343
doi: 10.1371/journal.pone.0148343
Gibbs RS (1980) Clinical risk factors for puerperal infection. Obstet Gynecol 55:178s–184s
doi: 10.1097/00006250-198003001-00045
Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ (1999) The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 20:725–730
doi: 10.1086/501572
Smaill FM, Grivell RM (2014) Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section. Cochrane Database Syst Rev 2014:Cd007482
Mackeen AD, Packard RE, Ota E, Berghella V, Baxter JK (2014) Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery. Cochrane Database Syst Rev 2014:9516
Currier JS, Tosteson TD, Platt R (1993) Cefazolin compared with cefoxitin for cesarean section prophylaxis: the use of a two-stage study design. J Clin Epidemiol 46:625–630
doi: 10.1016/0895-4356(93)90035-Y
ACOG Practice Bulletin No (2011) 120: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 117:1472–1483
doi: 10.1097/AOG.0b013e3182238c31
Young OM, Shaik IH, Twedt R et al (2015) Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery. Am J Obstet Gynecol 213(541):e1–e7
Maggio L, Nicolau DP, DaCosta M, Rouse DJ, Hughes BL (2015) Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial. Obstet Gynecol 125:1205–1210
doi: 10.1097/AOG.0000000000000789
Stitely M, Sweet M, Slain D et al (2013) Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug. Surg Infect (Larchmt) 14:455–459
doi: 10.1089/sur.2012.040
Ahmadzia HK, Patel EM, Joshi D et al (2015) Obstetric surgical site infections: 2 grams compared with 3 grams of cefazolin in morbidly obese women. Obstet Gynecol 126:708–715
doi: 10.1097/AOG.0000000000001064
Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 20:271–274
doi: 10.1016/S0196-6553(05)80201-9
Bratzler DW, Dellinger EP, Olsen KM et al (2013) Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 70:195–283
doi: 10.2146/ajhp120568

Auteurs

Mauricio La Rosa (M)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA. malarosa@utmb.edu.

Chasey Omere (C)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Tiffany Redfern (T)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Mahmoud Abdelwahab (M)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Nicholas Spencer (N)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Josephine Villarreal (J)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Gayle Olson (G)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

George R Saade (GR)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Antonio F Saad (AF)

The Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX, 77555-0587, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH